Madrigal Pharmaceuticals Ratios (2009-2025) | MDGL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2009	Jun2009	Sep2009	Dec2009	Mar2010	Jun2010	Sep2010	Dec2010	Mar2011	Jun2011	Sep2011	Dec2011	Mar2012	Jun2012	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Profitability
EBT Margin	-24.27%	9.99%	62.88%	-13.02%	-13.91%	-226.05%	-303.34%	-218.55%	-997.46%	-923.34%	-765.26%	-313.85%	-10,238.78%																-501.83%	-774.73%	-1,252.94%		-3,001.25%	-7,042.89%	-13,685.88%	-12,198.38%	-67,748.35%	-105,166.67%	-124,132.69%	-83,359.42%	15,477.02%	10,343.57%	14,175.74%	3,291.78%	2,957.60%	2,817.92%	2,825.33%	3,844.22%	-1,038.20%	-172.04%	-57.51%	-53.36%	-19.85%	-38.68%
EBIT Margin	-24.31%	10.09%	62.84%	-13.02%	-13.91%	-224.81%	-302.42%	-207.21%	-959.41%	-886.93%	-734.25%	-299.12%	-9,908.16%																-602.96%	-874.73%	-1,352.94%		-3,156.56%	-7,142.89%	-13,785.88%	-12,235.33%	-67,848.35%	-105,266.67%	-124,232.69%	-83,459.42%	15,377.02%	10,243.57%	14,075.74%	3,353.42%	2,980.01%	2,812.04%	2,950.79%	3,961.36%	-1,110.38%	-187.06%	-64.84%	-57.79%	-22.18%	-39.68%
EBITDA Margin	-24.31%	10.09%	0.06%	-13.02%	-13.91%	-224.81%	-302.42%	-207.21%	-959.41%	-886.93%	-734.25%	-299.12%	-9,908.16%																-602.96%	-874.73%	-1,352.94%		-3,156.56%	-7,142.89%	-13,785.88%	-12,235.33%	-67,848.35%	-105,266.67%	-124,232.69%	-83,459.42%	15,377.02%	10,243.57%	14,075.74%	3,353.42%	2,980.01%	2,812.04%	2,950.79%	3,961.36%	-1,110.38%	-187.06%	-64.84%	-57.79%	-22.18%	-39.68%
Operating Margin	-24.31%	10.09%	62.84%	-13.02%	-13.91%	-224.81%	-302.42%	-207.21%	-959.41%	-886.93%	-734.25%	-299.12%	-9,908.16%																-602.96%	-874.73%	-1,352.94%		-3,156.56%	-7,142.89%	-13,785.88%	-12,235.33%	-67,848.35%	-105,266.67%	-124,232.69%	-83,459.42%	15,377.02%	10,243.57%	14,075.74%	3,353.42%	2,980.01%	2,812.04%	2,950.79%	3,961.36%	-1,110.38%	-187.06%	-64.84%	-57.79%	-22.18%	-39.68%
Net Margin	-24.27%	0.00%	62.88%	-13.02%	-13.91%	-226.05%	-303.34%	-218.55%	-997.46%	-923.34%	-765.26%	-313.85%	-10,238.78%																-501.83%	-774.73%	-1,252.94%		-3,001.25%	-7,042.89%	-13,685.88%	-12,198.38%	-67,748.35%	-105,166.67%	-124,132.69%	-83,359.42%	15,477.02%	10,343.57%	14,175.74%	3,291.78%	2,957.60%	2,817.92%	2,825.33%	3,844.22%	-1,038.20%	-172.04%	-57.51%	-53.36%	-19.85%	-38.68%
FCF Margin	12.76%	1.79%	-16.40%	-13.56%	-18.91%	-223.04%	-251.11%	-204.09%	-1,124.15%	-900.22%	-726.20%	-317.50%	-10,476.87%															-214.51%	-383.99%	-409.33%	-593.54%	-1,648.13%	-2,015.37%	-5,814.46%	-12,721.53%	-10,039.95%	-51,519.78%	-76,010.00%	-92,623.08%	-72,413.04%	12,573.96%	7,528.92%	9,660.73%	3,600.26%	2,598.38%	2,433.19%	2,039.01%	3,895.62%	-922.78%	-108.99%	-101.32%	-64.77%	-22.11%	27.50%
Efficiency
Inventory Average																																																	0.00B	0.01B	0.02B	0.04B	0.06B	0.07B
Assets Average	0.09B	0.08B	0.06B	0.05B	0.06B				0.05B	0.05B	0.06B	0.05B	0.05B	0.05B	0.05B	0.08B	0.10B	0.08B	0.07B	0.08B	0.09B	0.10B	0.12B	0.11B	0.09B	0.09B	0.10B	0.29B	0.47B	0.46B	0.45B	0.43B	0.40B	0.36B	0.31B	0.30B	0.32B	0.32B	0.29B	0.25B	0.22B	0.19B	0.26B	0.35B	0.32B	0.27B	0.44B	0.86B	1.09B	1.09B	1.06B	1.02B	1.01B	1.19B
Equity Average											0.03B	0.02B	0.02B	0.03B	0.03B	0.05B	0.07B	0.05B	0.03B	0.03B	0.04B	0.06B	0.08B	0.02B	0.00B	0.06B	0.06B	0.26B	0.46B	0.45B	0.43B	0.40B	0.36B	0.32B	0.26B	0.25B	0.27B	0.25B	0.22B	0.17B	0.11B	0.05B	0.10B	0.17B	0.13B	0.06B	0.21B	0.63B	0.85B	0.82B	0.77B	0.73B	0.70B	0.66B
Invested Capital				0.03B				0.03B	0.01B	0.04B	0.03B	0.02B	0.04B	0.03B	0.04B	0.08B	0.06B	0.04B	0.02B	0.06B	0.05B	0.08B	0.09B	-0.03B	0.06B	0.08B	0.07B	0.47B	0.46B	0.44B	0.42B	0.39B	0.34B	0.29B	0.24B	0.26B	0.27B	0.23B	0.20B	0.15B	0.15B	0.08B	0.27B	0.26B	0.24B	0.17B	0.52B	0.97B	0.97B	0.89B	0.87B	0.83B	0.81B	0.97B
Asset Utilization Ratio	3.95	2.53	4.74	4.78	4.03				0.26	0.18	0.14	0.16	0.13														0.06	0.03	0.01	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.00	0.00	0.00	0.00	-0.01	-0.01	-0.01	-0.02	-0.03	-0.03	-0.02	0.00	0.06	0.17	0.31	0.51	0.62
Leverage & Solvency
Interest Coverage Ratio	234.35	99.45	-0.00B																																						-90.09	-53.54	-50.71	-33.53	-29.80	-28.12	-29.51	-39.61	-44.46	-31.61	-19.15	-24.06	-14.46	-15.30
Debt to Equity								0.64		0.46	0.68	1.13	0.49	0.80	0.45	0.17	0.42	0.67	1.61	0.47	0.54	0.25	0.19	-0.33	0.25	0.13	0.11														0.58	4.59	0.25	0.56	0.96	5.16	0.28	0.14	0.14	0.15	0.16	0.17	0.17	0.54
Debt Ratio								0.28	0.40	0.26	0.31	0.39	0.28	0.35	0.25	0.12	0.25	0.32	0.41	0.24	0.25	0.16	0.13	0.14	0.15	0.09	0.08														0.22	0.31	0.14	0.25	0.33	0.48	0.18	0.11	0.11	0.11	0.11	0.12	0.12	0.25
Equity Ratio				0.51				0.43		0.56	0.46	0.35	0.56	0.43	0.56	0.73	0.60	0.48	0.26	0.52	0.47	0.64	0.68	-0.42	0.58	0.68	0.66	0.98	0.97	0.97	0.94	0.94	0.88	0.85	0.84	0.84	0.83	0.77	0.72	0.65	0.39	0.07	0.54	0.45	0.34	0.09	0.63	0.79	0.78	0.72	0.72	0.71	0.69	0.46
Times Interest Earned	234.35	99.45	-0.00B																																						-90.09	-53.54	-50.71	-33.53	-29.80	-28.12	-29.51	-39.61	-44.46	-31.61	-19.15	-24.06	-14.46	-15.30
Valuation
Enterprise Value	0.06B	0.08B	0.05B	0.14B	0.09B	0.08B	0.13B	0.15B	0.28B	0.14B	0.11B	0.19B	0.17B	0.40B	0.42B	0.46B	0.50B	0.35B	0.38B	0.27B	0.29B	0.27B	0.19B	0.24B	0.14B	0.20B	0.19B	1.45B	1.15B	0.88B	0.97B	0.62B	1.36B	1.50B	1.44B	1.57B	1.29B	1.03B	1.18B	1.46B	1.01B	0.96B	4.61B	4.06B	3.93B	2.47B	3.93B	4.25B	4.91B	3.61B	5.80B	6.47B	5.92B	9.11B
Market Capitalization	0.07B	0.08B	0.11B	0.18B	0.15B	0.13B	0.16B	0.20B	0.28B	0.20B	0.16B	0.23B	0.23B	0.44B	0.47B	0.56B	0.59B	0.42B	0.44B	0.36B	0.37B	0.38B	0.31B	0.29B	0.21B	0.30B	0.24B	1.93B	1.62B	1.33B	1.41B	1.03B	1.75B	1.83B	1.72B	1.87B	1.62B	1.32B	1.45B	1.68B	1.22B	1.11B	4.96B	4.39B	4.22B	2.70B	4.57B	5.31B	5.97B	4.61B	6.73B	7.31B	6.72B	10.22B
Return Ratios
Return on Sales	-0.24%	-0.40%	0.20%	0.31%	0.42%	0.30%	-0.28%	-0.48%	-3.14%	-4.33%	-5.55%	-6.25%	-7.75%																-11.55%	-8.33%	-7.67%		-12.46%	-23.44%	-41.80%	-71.24%	-130.16%	-232.97%	-380.69%	-907.42%	927.16%	244.42%	166.02%	75.22%	49.76%	37.16%	29.39%	31.26%	-153.52%	-7.52%	-2.64%	-1.23%	-0.55%	-0.39%
Return on Capital Employed	-1.77%	1.22%	1.33%	2.16%	2.19%				-1.24%	-1.07%	-1.02%	-1.38%	-1.38%	-1.45%	-1.60%	-1.07%		-1.05%	-1.89%	-1.90%				-1.05%					-0.18%	-0.19%	-0.22%		-0.31%	-0.48%	-0.70%	-0.84%	-0.89%	-0.96%	-1.14%	-1.44%	-1.89%	-3.08%	-2.03%	-1.26%	-1.52%	-2.04%	-1.19%	-0.61%	-0.55%	-0.60%	-0.56%	-0.50%	-0.38%	-0.39%
Return on Assets	-0.95%	-1.01%	0.96%	1.49%	1.68%				-0.82%	-0.79%	-0.76%	-0.99%	-1.00%	-0.99%	-1.06%	-0.78%		-0.82%	-1.17%	-1.13%				-0.78%					-0.17%	-0.17%	-0.19%		-0.25%	-0.39%	-0.58%	-0.69%	-0.73%	-0.75%	-0.84%	-1.00%	-1.17%	-1.46%	-1.13%	-0.91%	-1.04%	-1.29%	-0.85%	-0.52%	-0.47%	-0.48%	-0.44%	-0.38%	-0.28%	-0.24%
Return on Equity											-1.49%	-2.41%	-2.10%	-1.96%	-2.10%	-1.17%		-1.49%	-3.05%	-2.69%				-4.21%					-0.18%	-0.18%	-0.20%		-0.28%	-0.45%	-0.68%	-0.82%	-0.87%	-0.94%	-1.12%	-1.44%	-2.23%	-5.82%	-2.84%	-1.81%	-2.60%	-5.52%	-1.75%	-0.71%	-0.60%	-0.63%	-0.61%	-0.53%	-0.40%	-0.43%

Research Tools

Madrigal Pharmaceuticals Ratios (2009-2025) | MDGL

Create an account

Sign In

Reset Password

Get Pro for 60% off